Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Interest & Investment Income: 2010-2015

Historic Interest & Investment Income for EyePoint Pharmaceuticals (EYPT) over the last 6 years, with Jun 2015 value amounting to $19,000.

  • EyePoint Pharmaceuticals' Interest & Investment Income rose 133.33% to $7,000 in Q2 2015 from the same period last year, while for Jun 2015 it was $19,000, marking a year-over-year increase of 216.67%. This contributed to the annual value of $19,000 for FY2015, which is 216.67% up from last year.
  • EyePoint Pharmaceuticals' Interest & Investment Income amounted to $19,000 in FY2015, which was up 216.67% from $6,000 recorded in FY2014.
  • EyePoint Pharmaceuticals' 5-year Interest & Investment Income high stood at $38,000 for FY2012, and its period low was $6,000 during FY2014.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Interest & Investment Income value was $16,000 (recorded in 2013), while the average stood at $13,667.
  • In the last 5 years, EyePoint Pharmaceuticals' Interest & Investment Income tumbled by 62.50% in 2014 and then skyrocketed by 216.67% in 2015.
  • Over the past 5 years, EyePoint Pharmaceuticals' Interest & Investment Income (Yearly) stood at $30,000 in 2011, then grew by 26.67% to $38,000 in 2012, then tumbled by 57.89% to $16,000 in 2013, then plummeted by 62.50% to $6,000 in 2014, then spiked by 216.67% to $19,000 in 2015.